- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02818192
Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study) (iCARE)
The overall aim of the project is to elucidate the primary bio-psycho-social (BPS) risk factors for albuminuria in youth with type 2 diabetes (T2D) and the mechanisms by which they cause renal injury. The Study Aims include:
- Characterize the primary BPS risk factors associated with prevalent and progressive albuminuria in youth with T2D.
- Determine individual, family and community level factors that influence biological and psychological risk factors and behaviors (adherence) that could be modified to protect against prevalent and progressive albuminuria.
- Determine if systemic and renal inflammation is the common pathway through which BPS risk factors lead to albuminuria in youth with T2D.
Study Hypotheses include:
- Biological factors (poor glycemic control and systolic ambulatory hypertension), and psychological and social adversity (stress, mental distress and poverty) are significant predictors of prevalent and progressive albuminuria in youth with T2D.
- Community and family support will be negatively associated with stress, and a lower risk of both prevalent and progressive albuminuria.
- Systemic and renal inflammation is the common pathway through which BPS risk factors lead to albuminuria in youth with T2D.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Brandy A Wicklow, MD, MSc
- Phone Number: 2047871222
- Email: bwicklow@hsc.mb.ca
Study Contact Backup
- Name: Melissa Del Vecchio, MSc
- Phone Number: 2047893827
- Email: mdelvecchio@chrim.ca
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 3P4
- Recruiting
- Children's Hospital Research Institute of Manitoba/University of Manitoba
-
Contact:
- Brandy A Wicklow, MD, MSc
- Phone Number: 2047871222
- Email: bwicklow@hsc.mb.ca
-
Principal Investigator:
- Brandy A Wicklow, MD, MSc
-
Principal Investigator:
- Allison Dart, MD, MSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All youth with T2D that do not meet exclusion criteria are eligible for the study.
Criteria for Diagnosis of T2D:
Diagnosis of diabetes will be made according to the Canadian Diabetes Association criteria. There must be 2 abnormal blood glucose tests on different days OR 1 abnormal blood glucose test + symptoms of diabetes:
- Fasting plasma glucose of > 7.0 mmol/L or
- Random glucose > 11.1mmol/L or
- 2 hour glucose > 11.1 mmol/L after a standard oral glucose tolerance test (75g).
Distinguishing T2D from type 1 diabetes (T1D) will be based on clinical risk factors including:
- Presence of overweight/obesity,
- Other evidence of insulin resistance (acanthosis nigricans)
- Family history of type 2 diabetes (1st degree relative)
- Intrauterine exposure to hyperglycemia,
- Family heritage from a high-risk ethnic group (Indigenous, Hispanic, South Asian, Asian or African descent)
- Absence of diabetes associated auto-antibodies
- HNF-1 alpha heterozygote or homozygote
Exclusion Criteria:
- Diabetes secondary to medication use or surgery
- Antibodies suggestive of type 1 diabetes
- Current treatment with oral steroids or immunosuppressive agents as they may interfere with cortisol assessment and inflammatory markers
- Ever cancer
- Other chronic illness associated with systemic inflammation (ex. Juvenile rheumatoid arthritis, Crohns disease)
- Patient and or caregiver unable or unwilling to provide voluntary informed assent/consent
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Persistent Albuminuria
Time Frame: 2 years
|
Persistent albuminuria Definition:
|
2 years
|
Change in albumin excretion over time.
Time Frame: 2 years
|
Change in albumin excretion over 2 years.
The change in albumin:creatinine ratio, treated as a continuous outcome measure was selected as a valid evaluation of progression of renal injury over time.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in estimated glomerular filtration rate (eGFR) over time.
Time Frame: 2 years
|
This outcome will be exploratory as significant changes are not expected during a 2-year follow-up period. However, as GFR reflects actual kidney function, this outcome will become increasingly important as chronic kidney disease (CKD) progresses in the cohort over time. GFR will be determined with serum creatinine measurements, utilizing a new eGFR formula for overweight youth, which have been validated utilizing iohexol GFR data from the initial cohort. eGFR will be calculated with the pediatric Schwartz formula and iCARE equation. This equation was previously validated for use in the iCARE cohort. |
2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Brandy A Wicklow, MD, MSc, University of Manitoba, Children's Hospital Research Institute of Manitoba
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B2011:024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
University of PadovaRecruitingStress | Stress Disorder | Work Related StressItaly
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Dana-Farber Cancer InstituteEnrolling by invitationStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
University of Sao PauloCompleted
-
Syracuse VA Medical CenterUS Department of Veterans AffairsCompletedEmotional Stress | Psychological Stress | Life StressUnited States
-
Royal Cornwall Hospitals TrustEnrolling by invitationStress | Stress, Psychological | Stress, JobUnited Kingdom
-
Northumbria UniversityVolac International LtdRecruitingStress | Mood | Physiological StressUnited Kingdom
-
Taichung Veterans General HospitalUnknown